Global Biologics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players and Competitive Strategies 2018-2026 - ResearchAndMarkets.com

June 12, 2018

DUBLIN--(BUSINESS WIRE)--Jun 12, 2018--The “Global Biologics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026” report has been added to ResearchAndMarkets.com’s offering.

The biologics market was valued at US$ 254.9 Bn in 2017, and expected to reach US$ 580.5 Bn by 2026, growing at a CAGR of 9.5% during the forecast period from 2018 to 2026.

Global biologics market exhibits remunerative growth during the forecast period from 2018 to 2026 due to presence of around 800 biologics in pipeline. The growth attributed is due to incessant expansion in product portfolio with increasing demand for biologics across the globe. Rising prevalence of chronic diseases, unremitting research and development activities and continuous investment in biologics contribute to the overall market growth.

Key Market Movements

Globally, biologics market continues to witness a lucrative growth with a CAGR of 9.5% for the period from 2018 to 2026 Presence of an extensive product portfolio and above 800 pipeline molecules, contributed to the overall growth of the market Among all the products available, recombinant therapeutic proteins maintains dominancy comprehending larger market share during the period from 2016 to 2026 The introduction of new cellular and gene therapy namely CAR-T cell provides better therapeutic outcome. Furthermore, research activities in this area contributes to the overall market growth during the forecast period.

Key Topics Covered

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Global Biologics Market: Dynamics and Future Outlook

Chapter 4. Global Biologics Market, by Product, 2016-2026 (US$ Bn)

Chapter 5. Global Biologics Market, by Disease, 2016-2026 (US$ Bn)

Chapter 6. Global Biologics Market, by Geography, 2016-2026 (US$ Bn)

Chapter 7. Company Profiles

Merck & Co. Inc. AbbVie, Inc. AstraZeneca Plc. Amgen, Inc. Celgene Corporation Bristol-Myers Squibb Co. Eli Lilly and Company Janssen Pharmaceuticals, Inc. GlaxoSmithKline Plc. Novartis AG Pfizer, Inc. Novo Nordisk A/S

For more information about this report visit https://www.researchandmarkets.com/research/rrw9rd/global_biologics?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180612006181/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biopharmaceuticals



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/12/2018 12:22 PM/DISC: 06/12/2018 12:22 PM


Update hourly